PARP1 and ovarian cancer: Several studies have shown that loss-of-function mutation of canonical HR factors – such as breast cancer type 1 and 2 (BRCA1/2) susceptibility proteins that are commonly associated with breast and ovarian cancer [13,14,15] – promotes PARP1 hyperactivation in fast replicating cancer cells [16,17].